Date: 2026-05-25Category: Press ReleaseState: Union GovernmentCountry: India
Indian Council of Medical Research organizes India’s largest biomedical innovation and technology transfer event “Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect” in New Delhi
**Executive Summary**
The Indian Council of Medical Research (ICMR) organized the “Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect” on May 25, 2026, in New Delhi to facilitate technology transfer in the biomedical sector. The event marked the launch of a first-of-its-kind platform to translate indigenous research into accessible healthcare solutions through industry partnerships. Key outcomes included the transfer of 41 public health technologies and critical biomaterials to industry partners to strengthen India's manufacturing ecosystem for "Viksit Bharat 2047."
**Key Points / Main Content**
* **Technology Transfer and Commercialization**
* Transfer of 41 public health technologies from ICMR institutes to industry partners for development and manufacturing.
* Technologies include glycoconjugate and recombinant vaccines for Typhoid and Paratyphoid.
* Diagnostic tools transferred for diseases including Japanese Encephalitis, Tuberculosis, and Mpox.
* Showcasing of over 100 technologies in diagnostics, therapeutics, and medical devices developed by startups and researchers.
* **Biomaterial Innovations**
* First-ever transfer of inactivated Kyasanur Forest Disease (KFD) and Chandipura virus biomaterials to industry.
* Aims to strengthen biomedical research and indigenous vaccine manufacturing capabilities.
* **Strategic Resources and Platforms**
* Launch of the "Innovators-to-Industry (I2I) Connect," a structured platform for biomedical innovation showcasing.
* Release of the ‘Indian Biomedical Patent Landscape Report’ to strengthen the intellectual property ecosystem.
* Release of the ‘Technology Compendium’ to document available biomedical innovations.
* **National Objectives**
* Transitioning India from a consumer of health technologies to a global source of affordable healthcare solutions.
* Accelerating the journey of indigenous research from laboratories to the public through Public-Private partnerships.
**Impact Analysis**
**ICMR and Research Institutions**
**Impact**
The initiative provides a structured pathway to protect intellectual property and move cutting-edge research out of laboratories. It validates indigenous research by connecting innovators directly with industry stakeholders.
**Action Required**
Institutes must continue to document and showcase developed technologies through the I2I platform and utilize the new Patent Landscape Report to guide future research.
**Industry Partners and Manufacturers**
**Impact**
Manufacturers gain access to well-characterized biomaterials and 41 ready-to-commercialize public health technologies, reducing the gap between research and market entry.
**Action Required**
Industry stakeholders must engage with the I2I Connect platform to take up these technologies for further development, large-scale manufacturing, and commercialization.
**Public Health Sector / Society**
**Impact**
Society benefits from the increased availability of affordable, indigenous vaccines and diagnostic tools for critical diseases like Tuberculosis and Mpox.
**Action Required**
No direct action is required from the public, though the sector will need to integrate these new indigenous technologies into healthcare delivery systems once commercialized.
Key Entities Referenced
Medical Innovations Patent Mitra: A structured initiative by ICMR designed to protect intellectual property, enable technology transfer, and accelerate the transition of indigenous biomedical research from labs to the public.
Indian Council of Medical Research (ICMR): The primary body responsible for organizing the technology transfer event and launching the innovation platform that transferred 41 public health technologies to industry partners.
Innovators-to-Industry (I2I) Connect: India’s largest biomedical innovation and technology transfer facilitation event established as a structured platform for showcasing innovations and fostering industry partnerships.
Indian Biomedical Patent Landscape Report: A key policy document released to strengthen the ecosystem for biomedical innovation, intellectual property, and technology transfer in India.
Department of Health Research (DHR): The nodal government department under the Ministry of Health and Family Welfare that oversees the ICMR and the implementation of biomedical research initiatives.
Ministry of Health and Family Welfare
Indian Council of Medical Research organizes
India’s largest biomedical innovation and
technology transfer event “Medical Innovations
Patent Mitra: Innovators-to-Industry (I2I)
Connect” in New Delhi
Union MoS Shri Prataprao Jadhav says India is emerging as a
global source of affordable healthcare technologies through
stronger science-industry partnerships
ICMR launches first-of-its-kind Innovator–Industry Platform,
transfers 41 Public Health Technologies to Industry
India witnesses first-ever transfer of inactivated KFD and
Chandipura virus biomaterials to industry partners to
strengthen biomedical research and vaccine manufacturing
“India has scientific capability to emerge as global leader in
health technologies”: Member, NITI Aayog Dr Gobardhan Das
Secy DHR & DG, ICMR Dr. Rajiv Bahl says Medical
Innovations Patent Mitra accelerates the journey of
indigenous biomedical research from laboratories to people
Posted On: 25 MAY 2026 4:57PM by PIB Delhi
The Indian Council of Medical Research (ICMR), under the Department of Health Research, Ministry of
Health and Family Welfare, Government of India, successfully organized “Medical Innovations Patent
Mitra: Innovators-to-Industry (I2I) Connect”—India’s largest biomedical and technology transfer
facilitation event today, at the Manekshaw Centre, New Delhi.
The event marked the establishment of one of the country’s first structured platforms dedicated to
biomedical innovation showcasing and technology transfer under the ICMR Medical Innovation Patent
Mitra initiative. The initiative aims to translate indigenous biomedical research into accessible, real-world
healthcare solutions through strong industry partnerships.The event was inaugurated by Shri Prataprao Ganpatrao Jadhav, Union Minister of State (Independent
Charge), Ministry of Ayush, and Minister of State, Ministry of Health and Family Welfare in presence of
Prof. Gobardhan Das, Member NITI.
Delivering the keynote address, the Minister of State Shri Jadhav said, “This initiative marks a decisive
step in connecting Indian science with industry, ensuring that innovations developed in our laboratories
translate into technologies that strengthen public health and advance Viksit Bharat. India is moving from
being a consumer of health technologies to becoming a global source of affordable and innovative
healthcare solutions, powered by institutions like ICMR and strong industry partnerships.”
Speaking on the occasion, Dr Gobardhan Das, Member, NITI Aayog said, “India has the scientific
capability and innovation ecosystem to emerge as a global leader in health technologies. Medical
Innovation Patent Mitra will play a crucial role in protecting intellectual property, enabling technology
transfer and accelerating the journey of indigenous innovations from laboratories to society.”
Dr. Rajiv Bahl, Director General, ICMR and Secretary, Department of Health Research, said, “Medical
Innovations Patent Mitra reflects ICMR’s commitment to ensuring that cutting-edge research moves
beyond laboratories to reach people through strong industry partnerships and impactful technology
transfer.”
During the event, the ‘Indian Biomedical Patent Landscape Report’ and the ‘Technology Compendium’
were also released, marking a significant step towards strengthening India’s biomedical innovation,
intellectual property and technology transfer ecosystem.
A major highlight of the event was the transfer of 41 public health technologies from ICMR institutes and
innovators to industry partners for further development, manufacturing and commercialization. These
technologies include advanced diagnostics, vaccines, medical devices and biomedical solutions addressing
critical public health priorities. Among the technologies transferred were glycoconjugate and recombinant
vaccines for Typhoid and Paratyphoid, as well as diagnostic technologies for diseases such as Japanese
Encephalitis, Tuberculosis and Mpox.
In another significant first, well-characterized biomaterials including inactivated KFD and Chandipura
viruses were also transferred to industry partners, strengthening India’s biomedical research and
manufacturing ecosystem. The event also showcased more than 100 technologies in diagnostics,
therapeutics and medical devices developed by ICMR institutes, researchers and startups, while
facilitating direct engagement between innovators and industry stakeholders.
Innovators and Industry connect initiative is expected to play a pivotal role in strengthening India’s
Biomedical sector for Viksit Bharat 2047 with stronger Public-Private partnership.***
SR/GS(Release ID: 2264989) Visitor Counter : 669
Read this release in: Telugu , Urdu , ही , Tamil